Similarly, in breast cancer patients, higher levels of HDAC6 are associated with smaller tumour size and low histological grade, in which the overexpression of HDAC6 is predominantly found in progesterone- and oestrogen-positive (ER+ve) tumours [34]. Here, HDAC6 is linked to neoplasm.